Prior to the transformation of a cell to a cancer cell, and even up to the early stages of cancer, TGF-β signaling typically exerts tumor-suppressive effects by inhibiting cell proliferation, inducing apoptosis, and maintaining genomic stability. The gene discussed is TGFB1; the disease is neoplasm.